Pharmaceutical giant Johnson & Johnson (J&J) (NYSE:JNJ) has announced plans to acquire Intra-Cellular Therapies (NASDAQ:ITCI) in a US$14.6 billion deal,…
Pharmaceutical giant Johnson & Johnson (J&J) (NYSE:JNJ) has announced plans to acquire Intra-Cellular Therapies (NASDAQ:ITCI) in a US$14.6 billion deal,…
Recent
View AllAs data breaches and cyberattacks rise, cybersecurity exchange-traded funds (ETFs) are gaining traction. The term cybersecurity originated in 1989,…
Zinc was among the best-performing base metals in 2024. It experienced a 13 percent gain, rising from US$2,621 per…
Rare earths prices saw some gains in May 2024, fueled by positive sentiment over consumer demand in China. While…
Barry Diller’s IAC said Monday that its board approved the spinoff of Angi, the home improvement marketplace the company acquired in 2017. IAC said…
Microsoft is forming a new group focused on developing AI apps and providing tools for third-party customers, the company announced…
Sen. Elizabeth Warren sent a letter to Pete Hegseth, President-elect Donald Trump’s nominee for Defense Secretary, laying out a…
Senate Minority Leader Chuck Schumer, D-N.Y., is meeting with Senate Armed Services Committee (SASC) Democrats on Monday evening to…
Special Counsel David Weiss blasted President Biden in his highly-anticipated report on his years-long investigation into Hunter Biden, saying…
As negotiations for a cease-fire between Israel and Hamas approach a decisive moment, the toll of the conflict continues…